プログラム委員会
-
Sabine Luik EFPIA Member ICH Steering Committee, Sr Vice President Medicine & Regulatory
Boehringer Ingelheim Pharmaceuticals, United States -
Pär Tellner, MPHARM, MSC, RPH Director, Regulatory Affairs
EFPIA, Belgium -
Steven Spanhaak, MSC Scientific Director
Janssen Research & Development, Belgium -
Fritz Erni, DRSC Consultant, ICH expert
Switzerland